JIOFIN trades at 1x FY27E P/BV.
Motilal Oswal
Following the recent reset, growth has rebounded meaningfully, led by stronger execution, expanded sales...
A ~15% correction in TIME’s scrip from its recent peak makes it more attractive...
We expect TBOTEK to deliver Revenue/EBIT/PAT CAGR of 35%/37%/32% over FY25- 28, primarily on...
Candere continues to scale strongly, supported by demand for lightweight and studded jewelry, with...
The company plans to increase its export mix to ~12% of revenues in FY27...
The combination of sustained APE growth, stable VNB margins, and disciplined cost management positions...
JIOFIN offers a compelling long-term growth runway, supported by the breadth of its financial...
MTARTECH is firmly positioning itself as the indirect beneficiary of the global AI infrastructure...
A key inflection in NACL’s evolution has been its calibrated yet decisive transition from...
